相关实验视频
Updated: Jul 5, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
15.9K
莱什曼病的诊断方面的进展和挑战
Sanjana Mehrotra1, Rahul Tiwari2, Rajiv Kumar3
1Department of Human Genetics, Guru Nanak Dev University, Amritsar, India.
Molecular diagnosis & therapy
|January 22, 2025
概括
新的诊断工具正在改善资源有限的地区的莱什曼病检测. 诸如定量PCR (qPCR) 和便携式测序等进展为这种被忽视的热带疾病提供了更快,更准确的临床检测.
科学领域:
- *热带医学和传染病诊断.
- * 生物技术和分子诊断.
背景情况:
- *莱什曼病对全球健康造成重大负担,特别是在资源有限的地区.
- * 传统的诊断方法 (显微镜,培养,血清学) 在灵敏度,速度和基础设施要求方面存在局限性.
- * 改善诊断策略对于有效的莱什曼病管理至关重要.
研究的目的:
- * 审查和分析莱什曼病诊断技术的最新进展.
- * 评估这些新方法在资源有限的环境中的适用性.
- * 评估这些创新对莱什曼病诊断和患者护理的潜在影响.
主要方法:
- * 关于莱什曼病新兴诊断技术的综合文献综述.
- * 分子测定分析:定量PCR (qPCR),循环介导同热放大 (LAMP),重组酶聚合酶放大 (RPA).
- *对治疗点 (POC) 技术的评估:纳米诊断,便携式测序 (例如,MinIONTM),芯片上的实验室平台.
主要成果:
- *像qPCR,LAMP和RPA这样的分子技术显著提高了诊断灵敏度和特异性.
- *这些方法可以准确地识别物种和检测亚临床感染.
- *新兴的POC技术为远程和现场设置提供了分散的诊断功能.
结论:
- * 尖端的诊断工具正在彻底改变莱什曼病的检测,克服传统方法的局限性.
- * 便携式和快速诊断解决方案为改善流行地区的莱什曼病控制提供了巨大的希望.
- *这些进展将改变莱什曼病诊断和管理的未来格局,特别是在服务不足的地区.
更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
22.3K
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.2K
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...